Signal Transducer and Activator of Transcription 3 is Involved in Cell Growth and Survival of Human Rhabdomyosarcoma and Osteosarcoma Cells

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2007 Jun 30

PMID 17598902

Citations 43

Authors

Chun-Liang Chen

Abbey Loy

Ling Cen

Christina Chan

Fu-Chuan Hsieh

Gong Cheng

Bryant Wu

Stephen J Qualman

Keita Kunisada

Keiko Yamauchi-Takihara

Jiayuh Lin

Affiliations

Soon will be listed here.

Abstract

Background: Stat3 has been classified as a proto-oncogene and constitutive Stat3 signaling appears to be involved in oncogenesis of human cancers. However, whether constitutive Stat3 signaling plays a role in the survival and growth of osteosarcomas, rhabdomyosarcomas, and soft-tissue sarcomas is still unclear.

Methods: To examine whether Stat3 is activated in osteosarcomas, rhabdomyosarcomas and other soft-tissue sarcomas we analyzed sarcoma tissue microarray slides and sarcoma cell lines using immunohistochemistry and Western blot analysis, respectively, with a phospho-specific Stat3 antibody. To examine whether the activated Stat3 pathway is important for sarcoma cell growth and survival, adenovirus-mediated expression of a dominant-negative Stat3 (Y705F) and a small molecule inhibitor (termed STA-21) were used to inhibit constitutive Stat3 signaling in human sarcoma cell lines expressing elevated levels of Stat3 phosphorylation. Cell viability was determined by MTT assays and induction of apoptosis was analyzed by western blotting using antibodies that specifically recognize cleaved caspases-3, 8, and 9.

Results: Stat3 phosphorylation is elevated in 19% (21/113) of osteosarcoma, 27% (17/64) of rhabdomyosarcoma, and 15% (22/151) of other soft-tissue sarcoma tissues as well as in sarcoma cell lines. Expression of the dominant-negative Stat3 and treatment of STA-21 inhibited cell viability and growth and induced apoptosis through caspases 3, 8 and 9 pathways in human sarcoma cell lines expressing elevated levels of phosphorylated Stat3.

Conclusion: This study demonstrates that Stat3 phosphorylation is elevated in human rhabdomyosarcoma, osteosarcomas and soft-tissue sarcomas. Furthermore, the activated Stat3 pathway is important for cell growth and survival of human sarcoma cells.

Citing Articles

Bazedoxifene as a Potential Cancer Therapeutic Agent Targeting IL-6/GP130 Signaling.

Shi C, Bopp T, Lo H, Tkaczuk K, Lin J Curr Oncol. 2024; 31(10):5737-5751.

PMID: 39451730 PMC: 11505662. DOI: 10.3390/curroncol31100426.

Interleukin-6 serves as a critical factor in various cancer progression and therapy.

Mohamed A, Ahmed A, Al Abdulmonem W, Olegovich Bokov D, Shafie A, Al-Hetty H Med Oncol. 2024; 41(7):182.

PMID: 38900329 DOI: 10.1007/s12032-024-02422-5.

Upregulation of CELSR1 expression promotes ovarian cancer cell proliferation, migration, and invasion.

Zuo J, Zheng A, Wang X, Luo Z, Chen Y, Cheng X Med Oncol. 2023; 41(1):10.

PMID: 38070011 DOI: 10.1007/s12032-023-02232-1.

Loss of Chemerin in Rhabdomyosarcoma Cells Polarizes Adjacent Monocytes to an Immunosuppressive Phenotype.

Sun R, Le Lin J, Cheng M, Lee K, Spruss T, Buechler C Biomedicines. 2022; 10(10).

PMID: 36289872 PMC: 9599404. DOI: 10.3390/biomedicines10102610.

Ectopic CD137 expression by rhabdomyosarcoma provides selection advantages but allows immunotherapeutic targeting.

Lee K, Wong H, Zeng Q, Le Lin J, Cheng M, Kuick C Oncoimmunology. 2021; 10(1):1877459.

PMID: 33643694 PMC: 7872024. DOI: 10.1080/2162402X.2021.1877459.

References

Chen C, Hsieh F, Lieblein J, Brown J, Chan C, Wallace J . Stat3 activation in human endometrial and cervical cancers. Br J Cancer. 2007; 96(4):591-9. PMC: 2360038. DOI: 10.1038/sj.bjc.6603597. View

Paglin S, Hollister T, Delohery T, Hackett N, McMahill M, Sphicas E . A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res. 2001; 61(2):439-44. View

Burke W, Jin X, Lin H, Huang M, Liu R, Reynolds R . Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells. Oncogene. 2001; 20(55):7925-34. DOI: 10.1038/sj.onc.1204990. View

Levy D, Lee C . What does Stat3 do?. J Clin Invest. 2002; 109(9):1143-8. PMC: 150972. DOI: 10.1172/JCI15650. View

Kamimura D, Ishihara K, Hirano T . IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol. 2003; 149:1-38. DOI: 10.1007/s10254-003-0012-2. View

Chen H, Chung S, Sukumar S . HOXA5-induced apoptosis in breast cancer cells is mediated by caspases 2 and 8. Mol Cell Biol. 2004; 24(2):924-35. PMC: 343791. DOI: 10.1128/MCB.24.2.924-935.2004. View

Barton B, Karras J, Murphy T, Barton A, Huang H . Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines. Mol Cancer Ther. 2004; 3(1):11-20. View

Yu H, Jove R . The STATs of cancer--new molecular targets come of age. Nat Rev Cancer. 2004; 4(2):97-105. DOI: 10.1038/nrc1275. View

Pedranzini L, Leitch A, Bromberg J . Stat3 is required for the development of skin cancer. J Clin Invest. 2004; 114(5):619-22. PMC: 514594. DOI: 10.1172/JCI22800. View

10.

Chan K, Sano S, Kiguchi K, Anders J, Komazawa N, Takeda J . Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J Clin Invest. 2004; 114(5):720-8. PMC: 514583. DOI: 10.1172/JCI21032. View

11.

Schindler C, Darnell Jr J . Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem. 1995; 64:621-51. DOI: 10.1146/annurev.bi.64.070195.003201. View

12.

Garcia R, Yu C, Hudnall A, Catlett R, Nelson K, Smithgall T . Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Cell Growth Differ. 1998; 8(12):1267-76. View

13.

Bromberg J, Horvath C, Besser D, Lathem W, Darnell Jr J . Stat3 activation is required for cellular transformation by v-src. Mol Cell Biol. 1998; 18(5):2553-8. PMC: 110635. DOI: 10.1128/MCB.18.5.2553. View

14.

Kuida K, Haydar T, Kuan C, Gu Y, Taya C, Karasuyama H . Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell. 1998; 94(3):325-37. DOI: 10.1016/s0092-8674(00)81476-2. View

15.

Hakem R, Hakem A, Duncan G, Henderson J, Woo M, Soengas M . Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell. 1998; 94(3):339-52. DOI: 10.1016/s0092-8674(00)81477-4. View

16.

Kunisada K, Tone E, Fujio Y, Matsui H, Kishimoto T . Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes. Circulation. 1998; 98(4):346-52. DOI: 10.1161/01.cir.98.4.346. View

17.

Li H, Zhu H, Xu C, Yuan J . Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 1998; 94(4):491-501. DOI: 10.1016/s0092-8674(00)81590-1. View

18.

Varfolomeev E, Schuchmann M, Luria V, Chiannilkulchai N, Beckmann J, Mett I . Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity. 1998; 9(2):267-76. DOI: 10.1016/s1074-7613(00)80609-3. View

19.

Gong W, Wang L, Yao J, Ajani J, Wei D, Aldape K . Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer. Clin Cancer Res. 2005; 11(4):1386-93. DOI: 10.1158/1078-0432.CCR-04-0487. View

20.

Song H, Wang R, Wang S, Lin J . A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells. Proc Natl Acad Sci U S A. 2005; 102(13):4700-5. PMC: 555708. DOI: 10.1073/pnas.0409894102. View